Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Special Education
      • Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • DSM-5’s First Pages and ICD-10’s Billing Codes
  • Medical & Educational Downloads
  • Contact Us
Select Page

What helps and hinders recovery from depression? A systematic review and qualitative evidence synthesis of patient-identified recovery factors

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Psychother Psychosom. 2025 Oct 30:1-26. doi: 10.1159/000548808. Online ahead of print. ABSTRACT INTRODUCTION: Depression is a common mental disorder with often persistent consequences. Even after adequate treatment, recovery may be far from optimal. To enhance...

Visceral Adiposity and Risk of Depression Independent of General and Central Adiposity: A Prospective Cohort Study

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Psychother Psychosom. 2025 Oct 30:1-18. doi: 10.1159/000549345. Online ahead of print. ABSTRACT OBJECTIVE: Visceral adipose tissue (VAT) is a metabolically active fat depot linked to cardiometabolic disease, but its relationship with depression independent of general...

A Systematic Review of the Effects of N-Methyl-D-Aspartate Receptor Antagonists on Pancreatic Islets

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Neuroendocrinology. 2025 Oct 30:1-26. doi: 10.1159/000549276. Online ahead of print. ABSTRACT Background N-methyl-D-aspartate receptors (NMDARs) are widely distributed in the brain and pancreas. Preliminary evidence indicates that aberrant NMDAR-mediated glutamatergic...

The importance of existential questions in patients with a depressive disorder – a pilot study

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Psychopathology. 2025 Oct 30:1-21. doi: 10.1159/000548702. Online ahead of print. ABSTRACT BACKGROUND: Depressive disorders are among the most common mental illnesses. Many approaches to treatment using psychotherapy or psychotropic drugs exist, but the proportion of...

TMS is needed in Public Mental Health Services

by jlohrconsulting | Oct 30, 2025 | Uncategorized

Australas Psychiatry. 2025 Oct 30:10398562251393795. doi: 10.1177/10398562251393795. Online ahead of print. ABSTRACT Transcranial magnetic stimulation (TMS) is essential for the comprehensive treatment of major depressive disorder (MDD). Around Australia, it is widely...

The Effects and Interactions of Epiretinal Electrical Stimulation Parameters on Direct and Network-Mediated Activation of Retinal Ganglion Cells

by jlohrconsulting | Oct 30, 2025 | Uncategorized

IEEE Trans Neural Syst Rehabil Eng. 2025 Oct 30;PP. doi: 10.1109/TNSRE.2025.3627290. Online ahead of print. ABSTRACT Neuromodulation efficacy and efficiency hinge on optimization of stimulation parameters like charge, phase width (PW), pulse rate, and waveform shape....
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments